- Home
- PESI vs NVCT Comparison
PESI vs NVCT Comparison
Compare PESI & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- NVCT
- Stock Information
- Founded
- PESI 1990
- NVCT 2020
- Country
- PESI United States
- NVCT United States
- Employees
- PESI N/A
- NVCT N/A
- Industry
- PESI Environmental Services
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- PESI Industrials
- NVCT Health Care
- Exchange
- PESI Nasdaq
- NVCT Nasdaq
- Market Cap
- PESI 208.0M
- NVCT 184.9M
- IPO Year
- PESI 1992
- NVCT 2022
- Fundamental
- Price
- PESI $12.33
- NVCT $7.78
- Analyst Decision
- PESI
- NVCT Strong Buy
- Analyst Count
- PESI 0
- NVCT 3
- Target Price
- PESI N/A
- NVCT $17.00
- AVG Volume (30 Days)
- PESI 146.3K
- NVCT 270.7K
- Earning Date
- PESI 08-07-2025
- NVCT 08-05-2025
- Dividend Yield
- PESI N/A
- NVCT N/A
- EPS Growth
- PESI N/A
- NVCT N/A
- EPS
- PESI N/A
- NVCT N/A
- Revenue
- PESI $59,419,000.00
- NVCT N/A
- Revenue This Year
- PESI $23.71
- NVCT N/A
- Revenue Next Year
- PESI $86.33
- NVCT N/A
- P/E Ratio
- PESI N/A
- NVCT N/A
- Revenue Growth
- PESI N/A
- NVCT N/A
- 52 Week Low
- PESI $6.25
- NVCT $4.44
- 52 Week High
- PESI $16.25
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- PESI 72.76
- NVCT 44.12
- Support Level
- PESI $12.13
- NVCT $7.70
- Resistance Level
- PESI $12.63
- NVCT $8.24
- Average True Range (ATR)
- PESI 0.35
- NVCT 0.44
- MACD
- PESI 0.07
- NVCT 0.03
- Stochastic Oscillator
- PESI 80.77
- NVCT 27.52
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.